Want to see MIRM full AI Analyst Report?
Mirum Pharmaceuticals (MIRM) Income Statement
Mirum Pharmaceuticals Income Statement
Last quarter (Q2 2026), Mirum Pharmaceuticals's total revenue was $176.24M, an increase of 37.92% from the same quarter last year. In Q2, Mirum Pharmaceuticals's net income was $-67.23M. See Mirum Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 521.31M | $ 336.89M | $ 186.37M | $ 77.06M | $ 19.14M | |
| $ 420.73M | $ 255.25M | $ 139.34M | $ 64.69M | $ 17.23M | |
| $ 443.21M | $ 342.85M | $ 248.49M | $ 195.91M | $ 190.65M | |
| Depreciation and Amortization | $ 24.24M | $ 23.63M | $ 10.83M | $ 3.24M | $ 975.00K |
| $ 17.21M | $ -48.97M | $ -136.49M | $ -122.85M | $ -65.39M | |
| $ -22.14M | $ -87.61M | $ -109.15M | $ -131.22M | $ -173.41M | |
| $ 709.00K | $ 694.00K | $ -53.27M | $ -10.85M | $ 89.46M | |
| $ -21.43M | $ -86.91M | $ -162.42M | $ -142.07M | $ -83.95M | |
| $ -23.36M | $ -87.94M | $ -163.41M | $ -135.66M | $ -83.99M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.47 | $ -1.85 | $ -4.00 | $ -4.01 | $ -2.77 |
| Diluted EPS | $ -0.47 | $ -1.85 | $ -4.00 | $ -4.02 | $ -2.77 |
| Weighted Average Shares Outstanding | 50.20M | 47.52M | 40.89M | 33.84M | 30.32M |
| Weighted Average Shares Outstanding (Diluted) | 50.20M | 47.52M | 40.89M | 33.98M | 30.32M |
Currency in USD
